Oculis intends to use the net proceeds from the Offering to advance and accelerate its clinical development pipeline, particularly the development of its novel neuroprotective clinical candidate ...

Satterthwaite demonstrated that combining both dividend yield and net repurchase yield into total shareholder yield is a far ...

International Petroleum Corporation Announces 2024 Year-End Financial and Operational Results and 2025 Budget, Reserves and ...

It's a simple but extraordinarily powerful force that anyone saving or going into debt should understand, says Tom Stevenson ...